Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Victoria Klepsch, Maria Pommermayr, Dominik Humer, Natascha Brigo, Natascha Hermann-Kleiter, Gottfried Baier

Journal title: Cell Communication and Signaling

Journal number: 18/1

Journal publisher: BioMed Central

Published year: 2020

DOI identifier: 10.1186/s12964-019-0454-z

ISSN: 1478-811X